Citation Impact

1 from Science/Nature 73 standout
Sub-graph 1 of 22

Citing Papers

Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
2023 Standout
Hepatocellular carcinoma
2022 Standout
2 intermediate papers

Works of H.-M. Chang being referenced

116MO Efficacy, safety, and quality of life (QoL) with futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements: FOENIX-CCA2
2020
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum
2012

Author Peers

Author PRM Surgery Oncology Epidemiology Neurology Last Decade Papers Cites
H.-M. Chang 487 205 135 300 281 24 806
Larissa Chirkova 3 13 2 9 13 552
L. A. Lehmann 115 9 2 5 5 16 516
Yoichiro Tokutake 3 6 13 2 1 3 453
A.A. Waller 4 6
R.N. West 1 35 540

All Works

Loading papers...

Rankless by CCL
2026